Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec.
Reichel FF, Seitz I, Wozar F, Dimopoulos S, Jung R, Kempf M, Kohl S, Kortüm FC, Ott S, Pohl L, Stingl K, Bartz-Schmidt KU, Stingl K, Fischer MD.
Reichel FF, et al. Among authors: fischer md.
Br J Ophthalmol. 2023 Sep;107(9):1331-1335. doi: 10.1136/bjophthalmol-2021-321023. Epub 2022 May 24.
Br J Ophthalmol. 2023.
PMID: 35609955